Filter
1538
Text search:
South
Pacific
Featured
129
338
Language
Document type
785
393
172
70
47
20
15
15
10
10
1
Countries / Regions
136
44
39
36
35
31
25
22
22
22
20
20
16
14
13
11
10
10
9
9
8
8
8
7
7
6
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
280
148
108
98
53
24
18
3
1
Toolboxes
204
135
124
118
90
68
63
61
50
41
38
35
33
31
31
22
22
21
10
8
5
5
5
2
The devastating impacts of the 2015–16 El Niño will be felt well into 2017. This crisis was predicted, yet overall, the response has been too little too late. The looming La Niña event may further hit communities that are already deeply vulnerable. To end this cycle of failure, there is an urgen
...
Global AIDS Update 2018
Closing Gaps
Breaking Barriers
Righting injustices
Recommendations for a public health approach
HIV/AIDS Programme
Policy Brief
Practical Guideline for collaborative interventions
Accessed: 08.11.2020
UNAIDS / 2016
HIV-related advocacy evaluation training for civil society organisations
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement
...
Internally displaced children are twice invisible in global and national data. First, because internally displaced people (IDPs) of all ages are often unaccounted for. Second, because age-disaggregation of any kind of data is limited, and even more so for IDPs.
Planning adequate responses to meet
...
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
Technical Report
AIDS Medicines and diagnostics service
July 2015
WHO recommends replacing western blotting and line immunoassays with simpler tests in HIV testing services. These simpler tests include rapid diagnostic tests (RDTs) that can be used at the point-of-care, and enzyme immunoassays (EIAs).
These tests get results to the client faster, produce accura
...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for
...
Public Report
PQMC 0001-001-04 WHO PQMC Public Report November/2016, version 8.0
